The EMPA-KIDNEY long term follow-up trial evaluated the long-term effects of empagliflozin in patients with CKD.
Check out the visual abstract by Oscar Durón and join the conversation in our upcoming #NephJC.
The EMPA-KIDNEY long term follow-up trial evaluated the long-term effects of empagliflozin in patients with CKD.
Check out the visual abstract by Oscar Durón and join the conversation in our upcoming #NephJC.